Chiron Investment Management LLC increased its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 32.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 61,741 shares of the company's stock after buying an additional 15,043 shares during the period. Colgate-Palmolive comprises 2.3% of Chiron Investment Management LLC's portfolio, making the stock its 17th largest holding. Chiron Investment Management LLC's holdings in Colgate-Palmolive were worth $6,409,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. M&G Plc increased its position in shares of Colgate-Palmolive by 88.8% in the 2nd quarter. M&G Plc now owns 79,975 shares of the company's stock worth $7,758,000 after purchasing an additional 37,616 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its position in shares of Colgate-Palmolive by 6.3% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 218,937 shares of the company's stock valued at $21,246,000 after buying an additional 12,988 shares during the last quarter. Great Valley Advisor Group Inc. grew its position in shares of Colgate-Palmolive by 7.4% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 8,163 shares of the company's stock valued at $792,000 after buying an additional 564 shares during the last quarter. ORG Partners LLC grew its position in shares of Colgate-Palmolive by 507.0% during the 2nd quarter. ORG Partners LLC now owns 6,422 shares of the company's stock valued at $614,000 after buying an additional 5,364 shares during the last quarter. Finally, GPS Wealth Strategies Group LLC grew its position in shares of Colgate-Palmolive by 49.4% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 6,430 shares of the company's stock valued at $624,000 after buying an additional 2,125 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.
Insider Activity
In related news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.37% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts recently commented on the company. Piper Sandler started coverage on Colgate-Palmolive in a report on Tuesday, September 24th. They set an "overweight" rating and a $121.00 target price on the stock. UBS Group raised their price objective on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. Stifel Nicolaus lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and cut their target price for the company from $105.00 to $101.00 in a research note on Monday, October 28th. Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and increased their price objective for the company from $107.00 to $109.00 in a research report on Monday, September 9th. Finally, Wells Fargo & Company cut their target price on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating on the stock in a research report on Monday, October 28th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $105.11.
Check Out Our Latest Stock Report on Colgate-Palmolive
Colgate-Palmolive Trading Down 0.6 %
NYSE CL traded down $0.58 during trading on Wednesday, hitting $93.31. The stock had a trading volume of 1,334,000 shares, compared to its average volume of 4,372,161. The firm has a 50 day moving average price of $96.16 and a 200 day moving average price of $98.66. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a twelve month low of $75.50 and a twelve month high of $109.30. The company has a market capitalization of $76.24 billion, a PE ratio of 27.02, a PEG ratio of 3.36 and a beta of 0.43.
Colgate-Palmolive Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.14%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive's payout ratio is 57.31%.
About Colgate-Palmolive
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.